Statistical analysis and fold change analysis identified nine top-ranking hypermethylated candidate genes (CDX2, CEI, DMC1, IMP-1, PDE3A, PENK, SIM2, VSX1, and ZNF312) in primary bladder tumors. This evidence concerns the gene SIM2 and urinary bladder neoplasm.